[68Ga]Ga-白细胞介素-2用于活化T淋巴细胞显像:生化表征与正常受试者I期研究
本研究开发了可在室温下用68Ga标记白细胞介素-2(IL2)的冻干药盒,比较了THP与NODAGA两种螯合剂及hrIL2与desIL2两种蛋白的偶联与标记效果。临床前结果显示[68Ga]Ga-THP-desIL2标记产率59.13±2.58%、放化纯度97.91±0.45%、对活化T细胞受体Kd=0.584 nM/L,且冻干药盒在-80°C可稳定保存6个月。在5名志愿者中进行的首次人体I期研究显示快速血浆清除、肾脏代谢、安全性和有利的剂量学。
要点
- THP-desIL2偶联效率最高,[68Ga]Ga-THP-desIL2标记产率59.13±2.58%、放化纯度97.91±0.45%。
- [68Ga]Ga-THP-desIL2对活化T细胞受体Kd=0.584 nM/L,临床前显示快速肾脏代谢和较低肝摄取。
- THP-desIL2冻干药盒在-80°C稳定保存6个月,I期5名志愿者显示安全性和有利剂量学。
核心结论
- 开发了可在GMP条件下室温标记的THP-desIL2高效冻干药盒,体外和体内结果优良。
- [68Ga]Ga-THP-desIL2人体PET/CT显示有利的剂量学和安全性,突显其在免疫介导疾病和癌症中的广泛应用潜力。
研究设计与样本
- 临床前研究比较hrIL2与desIL2分别偶联NODAGA和THP螯合剂的体外质量控制和BALB/c小鼠体内生物分布。
- 冻干药盒在-80°C储存最长6个月,用iTLC、HPLC和SDS-PAGE评估货架期。
- 首次人体I期研究在5名志愿者中进行多个时间点的[68Ga]Ga-THP-desIL2 PET/CT采集,评估生物分布和剂量学。
主要发现
- 质谱显示THP或NODAGA仅一分子结合于两种IL2蛋白的N末端,THP-desIL2偶联效率最高。
- [68Ga]Ga-THP-desIL2标记产率59.13±2.58%、放化纯度97.91±0.45%、对活化T细胞受体Kd=0.584 nM/L。
- [68Ga]Ga-THP-desIL2临床前显示快速肾脏代谢和较[68Ga]Ga-NODAGA-desIL2及[68Ga]Ga-THP-hrIL2更低的肝摄取。
- THP-desIL2冻干药盒在-80°C保存6个月仍维持高放化纯度和标记产率。
- I期研究显示快速血浆清除、肾脏代谢、安全性和有利的剂量学。
关键数值与推荐
- [68Ga]Ga-THP-desIL2标记产率59.13±2.58%、放化纯度97.91±0.45%。
- [68Ga]Ga-THP-desIL2对活化T细胞受体Kd=0.584 nM/L。
- THP-desIL2冻干药盒在-80°C稳定保存长达6个月。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to develop a ready-to-use kit for 68Ga-labelling of interleukin-2 (IL2) facilitating PET imaging of activated T-lymphocytes. METHODS: Human recombinant IL2 (hrIL2) and Aldesleukin (desIL2), conjugated with two different chelators (NODAGA and THP) were compared. Conjugated-IL2 was stored, freeze-dried at -80 °C and radiolabelled at room temperature. In vitro quality controls (iTLC, HPLC, SDS-PAGE, spectrometry and binding assays on activated T-lymphocytes) and in vivo biodistribution studies in BALB/c mice, were performed. The shelf life of the lyophilized kits was assessed up to 6 months of storage, by iTLC, HPLC and SDS-PAGE. First-in-human study was conducted in 5 volunteers by performing [68Ga]Ga-THP-desIL2 PET/CT acquisitions at several time-points, to assess biodistribution and dosimetry. RESULTS: Mass spectrometry showed that only one molecule of THP or NODAGA is bound to N-terminus of both IL2 proteins. The most efficient conjugation was observed for THP-desIL2. [68Ga]Ga-THP-desIL2 showed higher labelling yield (LY) (59.13 ± 2.58%), radiochemical purity (RCP) (97.91 ± 0.45%) and binding affinity to its receptor on activated T-cells (Kd = 0.584 nM/L) and a more favorable biodistribution in pre-clinical studies, with rapid kidney metabolism and lower liver uptake than [68Ga]Ga-NODAGA-desIL2 and [68Ga]Ga-THP-hrIL2. Lyophilized kit of THP-desIL2 remained stable at -80 °C up to 6 months maintaining high RCP and LY. Phase I study showed a rapid plasma clearance, renal metabolism, safety and favorable dosimetry. CONCLUSIONS: We developed an efficient lyophilized kit of THP-desIL2 for 68Ga-labelling at room temperature in GMP conditions, obtaining excellent in vitro and in vivo results. [68Ga]Ga-THP-desIL2 PET/CT studies in humans showed favorable dosimetry and safety, thus highlighting its potential for a wide range of clinical applications, particularly in immune-mediated diseases and cancer.
引用
- Signore A, Galli F, Varani M, et al. [68Ga]Ga-interleukin-2 for imaging activated T-lymphocytes: biochemical characterization and phase I study in normal subjects. Eur J Nucl Med Mol Imaging. 2025. PMID: 40590904. doi:10.1007/s00259-025-07430-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。